Rajarshi Nath
Rajarshi Nath publishes mostly in Organic Chemistry, Molecular Biology and Pharmacology, on topics such as Synthesis and biological activity, Cholinesterase and Neurodegenerative Diseases and Synthesis and Biological Evaluation.
- World rank
- #1,056,423 of 7,710,434 ranked researchers
- Rank in Oman
- #253 of 1,991
- Works
- 43
- Citations
- 421
- Citations per work
- 9.8
What does Rajarshi Nath research?
Rajarshi Nath's work is mostly in Chemistry (39%), Medicine (14%), Biochemistry, Genetics and Molecular Biology (13%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Physical Sciences1943.2%
- Chemistry1739.0%
- Computer Science24.2%
- Everything else1330.6%
- Health Sciences613.5%
- Medicine613.5%
- Life Sciences512.7%
- 1Organic Chemistry39% of their works
- 2Molecular Biology13% of their works
- 3Pharmacology8% of their works
- 4Computational Theory and Mathematics4% of their works
- 5Infectious Diseases3% of their works
- 6Endocrinology, Diabetes and Metabolism2% of their works
Research topics
- Synthesis and biological activity
- Cholinesterase and Neurodegenerative Diseases
- Synthesis and Biological Evaluation
- Computational Drug Discovery Methods
- Synthesis and Characterization of Heterocyclic Compounds
- Click Chemistry and Applications
- Synthesis and Catalytic Reactions
- Enzyme function and inhibition
Which keywords describe Rajarshi Nath's research?
The keywords of their largest research topics: Medicinal Chemistry, Anticancer Agents, Heterocyclic Compounds, Tubulin Inhibitors, Vascular Targeting Agents, Synthesis, Drug Discovery and Biological Evaluation.
- Carbonic Anhydrases
- Amination
- Copper-Catalyzed Cycloaddition
- Antimicrobial
- Quinoxaline
- Antimicrobial Activity
- Acetylcholinesterase
- Biological Evaluation
- Synthesis
- Tubulin Inhibitors
- Anticancer Agents
- Medicinal Chemistry
- Heterocyclic Compounds
- Vascular Targeting Agents
- Drug Discovery
- Molecular Docking
- Cholinesterase Inhibitors
- Drug Target Identification
- Virtual Screening
- Click Chemistry
- Triazines
- Catalytic
- Inhibitors
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 23 words, with their numbers
- Medicinal Chemistry284 topics
- Anticancer Agents223 topics
- Heterocyclic Compounds202 topics
- Tubulin Inhibitors151 topic
- Vascular Targeting Agents151 topic
- Synthesis123 topics
- Drug Discovery103 topics
- Biological Evaluation92 topics
- Molecular Docking92 topics
- Acetylcholinesterase61 topic
- Cholinesterase Inhibitors61 topic
- Antimicrobial Activity51 topic
- Drug Target Identification51 topic
- Quinoxaline51 topic
- Virtual Screening51 topic
- Antimicrobial41 topic
- Click Chemistry41 topic
- Copper-Catalyzed Cycloaddition41 topic
- Triazines41 topic
- Amination31 topic
- Catalytic31 topic
- Carbonic Anhydrases21 topic
- Inhibitors21 topic
Where does Rajarshi Nath work?
Rajarshi Nath's main affiliation in the publication record is National University of Science and Technology, Oman.
How many publications and citations does Rajarshi Nath have?
OpenAlex counts 43 works and 421 citations for Rajarshi Nath, an h-index of 10, ranking #1,056,423 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Rajarshi Nath. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.